GIANT CELL ARTERITIS
Clinical trials for GIANT CELL ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL ARTERITIS trials appear
Sign up with your email to follow new studies for GIANT CELL ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cheaper drug may match expensive biologic in artery disease
Disease control OngoingThis study compares two treatments—methotrexate and tocilizumab—for giant cell arteritis, a disease that causes inflammation in large arteries. About 230 adults over 50 will receive one of the drugs for 12 months to see which better prevents relapses while reducing steroid use. T…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New study tests best way to stop arthritis drug without relapse
Disease control OngoingThis study looks at 120 adults with giant cell arteritis (a type of blood vessel inflammation) who are stable on tocilizumab. Researchers want to see if gradually reducing the drug is better than stopping it all at once for preventing the disease from flaring up again. Participan…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New imaging methods aim to pinpoint painful muscle disease
Diagnosis OngoingThis study explores whether ultrasound and PET/CT scans can more accurately diagnose and track polymyalgia rheumatica (PMR), a condition causing muscle pain and stiffness. Researchers will follow 98 adults over age 50 suspected of having PMR, using imaging at key points during st…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: Kresten Krarup Keller • Aim: Diagnosis
Last updated Apr 29, 2026 15:15 UTC